Effects of laser photodynamic therapy on tumor phosphate levels and pH assessed by 31P-NMR spectroscopy
- PMID: 2533522
Effects of laser photodynamic therapy on tumor phosphate levels and pH assessed by 31P-NMR spectroscopy
Abstract
The effects of photodynamic therapy using 632 nm photoradiation emitted from an ion pumped dye laser system on the phosphate metabolite levels of rat mammary tumors were monitored by 31P-NMR spectroscopy. A dramatic decline to almost undetectable levels, in the ratio of whole tumor beta-ATP (NTP) to Pi was observed after systemic administration of 5 mg/kg Photofrin II 24 h prior to exposure of R3230AC rat mammary tumor to laser irradiation at 180 and 360 J/cm2 total fluence. This decline in ATP was accompanied by a concomitant increase in the levels of Pi relative to the total observable phosphate signals. Whole tumor pH was calculated from the chemical shift in inorganic phosphate using the water proton signal as reference. Under the same treatment conditions used to monitor the phosphate metabolites following Photodynamic Therapy, the pH of the tumor as a whole decreased approximately 0.35 units at the time when the beta-ATP to Pi ratios were lowest. This maximal decrease in whole tumor ATP levels and pH, which occurred at 4-6 h post irradiation, was followed by a gradual return to pre-treatment levels over a 24 h period. These results demonstrate that Photodynamic Therapy employing porphyrin photosensitization and monochromatic laser irradiation is effective in reducing both tumor high energy phosphate levels and pH. Depending on sensitizer dose and light fluence, metabolic inhibition, represented by depleted nucleoside triphosphates and elevated Pi, may be reversible.
Similar articles
-
Dose-dependent metabolic response of mammary carcinoma to photodynamic therapy.Radiat Res. 1990 Mar;121(3):288-94. Radiat Res. 1990. PMID: 2315447
-
Dietary fat modulation of murine mammary tumor metabolism studied by in vivo 31P-nuclear magnetic resonance spectroscopy.Cancer Res. 1987 Nov 1;47(21):5631-6. Cancer Res. 1987. PMID: 3664470
-
Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas.Cancer Res. 1988 Jun 15;48(12):3360-6. Cancer Res. 1988. PMID: 2836053
-
Photodynamic therapy: principles and urologic applications.Semin Urol. 1991 Aug;9(3):192-202. Semin Urol. 1991. PMID: 1835115 Review. No abstract available.
-
Photosensitization of malignant tumors.Semin Surg Oncol. 1986;2(1):24-37. doi: 10.1002/ssu.2980020104. Semin Surg Oncol. 1986. PMID: 2946066 Review.
Cited by
-
Current status of photodynamic therapy in oncology.Drugs. 1994 Oct;48(4):510-27. doi: 10.2165/00003495-199448040-00003. Drugs. 1994. PMID: 7528127 Review.
-
Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy.Br J Cancer. 1991 Jun;63(6):916-22. doi: 10.1038/bjc.1991.201. Br J Cancer. 1991. PMID: 1829953 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous